Insider · CIK 0001236922

BANSAL AJAY

Reports to the SEC for 6 companies · MOUNTAIN VIEW, CA

sec.gov

Transactions

Companies

Filings

CIK

0001236922

Forms 4 and 5

Insider transactions

47 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-03-29	Urovant Sciences Ltd.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−24.9K sh	—	—	0
2021-03-29	Urovant Sciences Ltd.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−140K sh	—	—	0
2021-03-29	Urovant Sciences Ltd.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−115K sh	—	—	0
2020-05-01	Urovant Sciences Ltd.A Award	See Remarks	AAward	+63.7K sh	—	—	138,659
2019-11-05	Urovant Sciences Ltd.A Award	See Remarks	AAward	+75K sh	—	—	75,000
2019-11-05	Urovant Sciences Ltd.Stock Option (Right to Buy)A Award	See Remarks	AAward	+140K sh	—	—	140,000
2019-07-25	ViewRay, Inc.X Exercise of In-Money	Chief Financial Officer	XExercise of In-Money	+12.5K sh	$3.17	+$39.7K	103,284
2019-07-25	ViewRay, Inc.Warrant to Purchase Common StockX Exercise of In-Money	Chief Financial Officer	XExercise of In-Money	−12.5K sh	$0.13	−$1,564.875	0
2019-07-25	ViewRay, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−4,408 sh	$9.00	−$39.7K	98,876
2019-03-01	ViewRay, Inc.A Award	Chief Financial Officer	AAward	+20.7K sh	—	—	90,765
2019-03-01	ViewRay, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+36K sh	—	—	36,038
2018-04-16	ViewRay, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+110K sh	—	—	110,000
2017-02-18	ViewRay, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2017-01-23	ViewRay, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+104K sh	—	—	103,537
2017-01-18	ViewRay, Inc.P Purchase	Chief Financial Officer	PPurchase	+62.6K sh	$3.17	+$198K	70,104
2017-01-18	ViewRay, Inc.Warrant to Purchase Common StockP Purchase	Chief Financial Officer	PPurchase	+12.5K sh	$0.13	+$1,564.875	12,519
2016-12-15	ViewRay, Inc.A Award	Chief Financial Officer	AAward	+7,507 sh	—	—	7,507
2016-09-13	ViewRay, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+59.8K sh	—	—	59,832
2016-06-14	ViewRay, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+550K sh	—	—	550,000
2016-01-26	TRAWTraws Pharma, Inc. · Stock Option (right to purchase)A Award	Chief Financial Officer	AAward	+70K sh	—	—	69,984
2015-09-25	TRAWTraws Pharma, Inc. · Stock Option (right to purchase)A Award	Chief Financial Officer	AAward	+32.5K sh	—	—	32,500
2015-04-16	TRAWTraws Pharma, Inc. · Stock Option (right to purchase)A Award	Chief Financial Officer	AAward	+32.5K sh	—	—	32,500
2014-12-18	TRAWTraws Pharma, Inc. · Stock Option (right to purchase)A Award	Chief Financial Officer	AAward	+65K sh	—	—	65,000
2013-12-20	TRAWTraws Pharma, Inc. · Stock Option (right to purchase)A Award	Chief Financial Officer	AAward	+65K sh	—	—	65,000
2013-07-30	TRAWTraws Pharma, Inc.C Conversion	Chief Financial Officer	CConversion	+23.8K sh	—	—	43,846
2013-07-30	TRAWTraws Pharma, Inc. · Series B Convertible Preferred StockC Conversion	Chief Financial Officer	CConversion	−28.2K sh	—	—	0
2013-07-25	TRAWTraws Pharma, Inc. · Stock Option (right to purchase)A Award	Chief Financial Officer	AAward	+5,000 sh	—	—	5,000
2013-07-25	TRAWTraws Pharma, Inc. · Stock Option (right to purchase)A Award	Chief Financial Officer	AAward	+40K sh	—	—	40,000
2013-03-18	COMPLETE GENOMICS INCStock Option (right to buy)D Disposition to Issuer	SVP & Chief Financial Officer	DDisposition to Issuer	−50K sh	$0.14	−$7,000	0
2013-03-18	COMPLETE GENOMICS INCStock Option (right to buy)D Disposition to Issuer	SVP & Chief Financial Officer	DDisposition to Issuer	−128K sh	$0.46	−$58.9K	0
2013-03-14	COMPLETE GENOMICS INCD Disposition to Issuer	SVP & Chief Financial Officer	DDisposition to Issuer	−1,696 sh	$3.15	−$5,342.4	0
2012-04-02	COMPLETE GENOMICS INCStock Option (Right to buy)A Award	SVP & Chief Financial Officer	AAward	+50K sh	—	—	50,000
2011-04-11	COMPLETE GENOMICS INCStock Option (Right to buy)A Award	SVP & Chief Financial Officer	AAward	−70K sh	—	—	70,000
2011-04-11	COMPLETE GENOMICS INCStock Option (Right to buy)A Award	SVP & Chief Financial Officer	AAward	+70K sh	—	—	70,000
2009-06-02	LXRXLEXICON PHARMACEUTICALS, INC. · Employee Stock Option (right to buy)A Award	EVP Corp Dev and CFO	AAward	+250K sh	—	—	250,000
2005-09-07	NKTRNEKTAR THERAPEUTICSS Sale	CFO, VP Finance & Admin	SSale	−3,000 sh	$19.96	−$59.9K	0
2005-09-07	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	CFO, VP Finance & Admin	MExercise/Conversion	+3,000 sh	$5.43	+$16.3K	0
2005-09-07	NKTRNEKTAR THERAPEUTICS · Employee Stock Option (Right to Buy)D Disposition to Issuer	CFO, VP Finance & Admin	DDisposition to Issuer	−3,000 sh	—	—	95,500
2005-05-17	NKTRNEKTAR THERAPEUTICSA Award	CFO, VP Finance & Admin	AAward	+4,166 sh	—	—	4,166
2005-05-17	NKTRNEKTAR THERAPEUTICSS Sale	CFO, VP Finance & Admin	SSale	−4,166 sh	$16.41	−$68.4K	0
2005-05-17	NKTRNEKTAR THERAPEUTICS · Restricted Stock UnitD Disposition to Issuer	CFO, VP Finance & Admin	DDisposition to Issuer	−4,166 sh	—	—	30,834
2005-02-09	NKTRNEKTAR THERAPEUTICS · Restricted Stock UnitA Award	CFO, VP Finance & Admin	AAward	+10K sh	$0.01	+$100	—
2005-02-09	NKTRNEKTAR THERAPEUTICS · Stock Option (Right to Buy)A Award	CFO, VP Finance & Admin	AAward	+20K sh	$18.54	+$371K	—
2005-01-03	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	CFO, VP Finance & Admin	MExercise/Conversion	+7,000 sh	$5.43	+$38K	25,000
2005-01-03	NKTRNEKTAR THERAPEUTICS · Employee Stock Option (Right to Buy)D Disposition to Issuer	CFO, VP Finance & Admin	DDisposition to Issuer	−7,000 sh	—	—	78,500
2005-01-03	NKTRNEKTAR THERAPEUTICSS Sale	CFO, VP Finance & Admin	SSale	−7,000 sh	$20.06	−$140K	25,000
2004-03-01	NKTRNEKTAR THERAPEUTICSA Award	CFO, VP Finance & Admin	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Mar 314
BANSAL AJAY0000899243-21-014104
SEC(opens sec.gov)
May 44
BANSAL AJAY0001209191-20-026835
SEC(opens sec.gov)
Nov 54
BANSAL AJAY0001209191-19-055358
SEC(opens sec.gov)
Jul 294
BANSAL AJAY0001209191-19-043544
SEC(opens sec.gov)
Mar 54
BANSAL AJAY0001209191-19-016568
SEC(opens sec.gov)
Apr 184
BANSAL AJAY0000950103-18-004927
SEC(opens sec.gov)
Feb 234
ViewRay, Inc.0001140361-17-008882
SEC(opens sec.gov)
Jan 254
ViewRay, Inc.0001140361-17-002895
SEC(opens sec.gov)
Jan 204
ViewRay, Inc.0001140361-17-002419
SEC(opens sec.gov)
Dec 194
ViewRay, Inc.0001140361-16-090205
SEC(opens sec.gov)
Sep 154
ViewRay, Inc.0001140361-16-079939
SEC(opens sec.gov)
Jun 164
ViewRay, Inc.0001140361-16-069980
SEC(opens sec.gov)
Jan 284
Onconova Therapeutics, Inc.0001179110-16-018082
SEC(opens sec.gov)

Companies

Address

C/O COMPLETE GENOMICS, INC. 2071 STIERLIN COURT

MOUNTAIN VIEW, CA, 94043-4655